Prøve GULL - Gratis
How India Inc. is navigating tariff fog
Mint Mumbai
|September 08, 2025
To counter US tariffs, Indian industry must expand to other markets including Latin America and Russia, corporate leaders said at aMint roundtable.
-
It is not an easy time to head a business in India—whether local or multinational.TheUStariffsof50%onIndian export shit sector such as textiles and apparel,and gems and jewellery.Auto components,too, face pressures given their reliance on exports to theUS.Renewable energy firms, meanwhile,are less directly affectedbyWashington’stariffstrikes,but remain deeply dependent on remain deeply dependent on China for technology and inputs. The recent easing of Sino-Indian tensions has offered some reassurance, but nerves remain raw.
To deliberate on these issues and explore both risks and opportunities, Mint convened a leadership roundtable in New Delhi with leaders across textiles, renewable energy, mining, electronics, auto components and law.
What emerged were not just sectoral stories, but common threads that reveal how Indian businesses are thinking about survival and growth-in turbulent times.
Few issues loomed larger than China.
For the renewable energy industry, the dependence is stark. "China is the biggest part of our supply chain, so anything that happens with China is the biggest risk for us," said Nikhil Dhingra, chief executive officer (CEO) of renewable power producer ACME Solar. Even as India expands its domestic manufacturing base, critical technology is still imported.
Denne historien er fra September 08, 2025-utgaven av Mint Mumbai.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Mumbai
Mint Mumbai
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Mint Mumbai
EC extends electoral roll revision by a week to II Dec; final list on 14 Feb
The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.
2 mins
December 01, 2025
Mint Mumbai
THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS
These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.
3 mins
December 01, 2025
Mint Mumbai
Green hydrogen: Fast fashion could help bump up demand
A boom in its use for clean synthetic inputs might make a difference
3 mins
December 01, 2025
Mint Mumbai
Let's be a bit more selective in using the word 'reforms'
Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.
3 mins
December 01, 2025
Mint Mumbai
As mid-cap alpha shrinks, should you consider passive strategies?
Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey
4 mins
December 01, 2025
Mint Mumbai
With $2.2 bn fund, ChrysCap has appetite for riskier bets
MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing
3 mins
December 01, 2025
Mint Mumbai
GDP growth of 8% plus: How to sustain this pace
Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships
2 mins
December 01, 2025
Mint Mumbai
INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES
Detection tools today are not universal or consistent across languages
5 mins
December 01, 2025
Mint Mumbai
APIs to innovation: Bulk drug makers ramp up CDMO bets
Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.
2 mins
December 01, 2025
Listen
Translate
Change font size

